Oppenheimer Hires Suraj Kalia As Managing Director And Senior Analyst In Medical Technology And Devices

Date : 10/07/2019 @ 5:30PM
Source : PR Newswire (US)
Stock : Oppenheimer Holdings Inc (OPY)
Quote : 27.44  0.0 (0.00%) @ 2:20PM

Oppenheimer Hires Suraj Kalia As Managing Director And Senior Analyst In Medical Technology And Devices

Oppenheimer (NYSE:OPY)
Historical Stock Chart

2 Months : From Sep 2019 to Nov 2019

Click Here for more Oppenheimer Charts.

NEW YORK, Oct. 7, 2019 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced that Suraj Kalia has joined the Firm as Managing Director and Senior Medical Technology Analyst.  

Kalia covers Medical Technology and Devices within Oppenheimer's Healthcare Research franchise. He is responsible for providing clients with expert insight on the growing medical technology and devices sector. He brings more than 15 years of sell-side research experience to this role.

"Suraj's proven track record of delivering precise, cutting-edge analysis of the medical technology sector supports our mission of providing our clients with insights from the brightest minds in the industry," said John Parks, Managing Director & Director of Equity Research. "He has appeared on several esteemed rankings and lists by prominent publications, and his research is well-recognized. Given Oppenheimer's core focus on this industry, Suraj is the perfect addition to our team of experts."

Prior to joining Oppenheimer, Kalia was a Managing Director and Senior MedTech Analyst at Northland Securities, where he was ranked as the top Healthcare Equipment and Supplies Analyst by Thomson Reuters in 2018. His acclaimed market and company-specific research focused on Obstructive Sleep Apnea, Refractory Hypertension, Obesity, Epilepsy and Refractory Depression. Kalia was also a Managing Director and Senior Medical Device Analyst at Rodman & Renshaw, and a Senior Medical Device Analyst at Piper Jaffray & Co.

Kalia holds a bachelor's degree in technology, chemical engineering from the Indian Institute of Technology Bombay and a master's degree in chemical engineering from Stevens Institute of Technology. He also holds a Master of Business Administration from the University of St. Thomas and the CFA certification. He is based in New York City.

Oppenheimer & Co. Inc
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Cision View original content:http://www.prnewswire.com/news-releases/oppenheimer-hires-suraj-kalia-as-managing-director-and-senior-analyst-in-medical-technology-and-devices-300933144.html

SOURCE Oppenheimer & Co. Inc.

Copyright 2019 PR Newswire

Latest OPY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.